JSE-listed healthcare, electronics and baby retailer Clicks will sell its shareholding in Unicorn Pharmaceuticals, the group announced in a statement on Sens on Monday.
The Department of Health subsequently told Clicks that no new pharmacy licence applications would be processed until Clicks complied with the Constitutional Court ruling. “As part of a constructive engagement process with the Director-General and the Department of Health, Clicks Group proposed to regularise its position by the group divesting of its total shareholding in the manufacturing pharmacy, Unicorn Pharmaceuticals Ltd,” the group noted.The Director-General accepted this proposal on Thursday, 27 June 2024.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: